Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 585 - 592 of 12009 results
Caveat Employer: An Employee’s Off-Duty Social Media Posts Can Constitute Workplace Harassment
September 16, 2024| Blog| Viewpoint
Biglaw Firm Gives All Employees Paid Day Off To Vote, Volunteer On Election Day
September 16, 2024| News
Federal Circuit Rejects Google’s Bid To Shrink ITC Jurisdiction over Post-Importation Acts of Indirect Infringement
September 12, 2024| Blog| Viewpoint
NIST Releases Updated Draft Guidance for Federal Agencies’ Use of AI in Identity Verification Systems — AI: The Washington Report
September 12, 2024| Article| Viewpoint
2024 Pre-Election Analysis: Infrastructure
September 12, 2024| Advisory| Viewpoint
Texas Challenges HHS’s HIPAA Rule Protecting Reproductive Health Information from State Investigative Bodies
September 12, 2024| Blog| Viewpoint
Understanding Post-Bankruptcy Liquidation Trusts
September 10, 2024| Blog| Viewpoint
The Fiduciary How (And Why) 401k Plan Sponsors Change Recordkeepers
September 10, 2024| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|